Lipoproten-mediated transport of dietary and synthesized lipids and lipid abnormalities of dog and cats

Journal of the American Veterinary Medical Association

Volumn 224, Issue 5, 2004, Pages 668-675

  Bauer, John E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; LIPID;

ATHEROSCLEROSIS; CAT; CIRCULATION; DOG; DYSLIPIDEMIA; FAT INTAKE; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; LIPID TRANSPORT; LIPOGENESIS; LIPOPROTEIN METABOLISM; NONHUMAN; REVIEW; ANIMAL; ANIMAL FOOD; BLOOD; CAT DISEASE; DOG DISEASE; HUMAN; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

CANIS FAMILIARIS; FELIS CATUS;

ANIMAL FEED; ANIMALS; BIOLOGICAL TRANSPORT; CAT DISEASES; CATS; DIETARY FATS; DOG DISEASES; DOGS; HUMANS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS;

EID: 1542288768     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.224.668     Document Type: Review

References (49)

1. Machebouef MA. Recherches sur les phosphoaminolipids et les sterides du serum et du plasma sanguins. Bull Soc Chim Biol (Paris) 1929;11:268-269.
2. Oncley JL, Scatchard G, Brown A. Physical-chemical characteristics of certain proteins of normal human plasma. J Physiol Chem 1947;51:184-198.
3. Gofman JW, Lindgren FT, Elliott H. Ultracentrifugal studies of lipoproteins of human serum. J Biol Chem 1949;179:973-979.
4. Bierman EL. Disorders of the vascular system. In: Wilson JE, Braunwald E, Isselbacher JK, et al, eds. Harrison's principles of internal medicine. 12th ed. New York: McGraw-Hill Book Co, 1991;992-1001.
5. National Cholesterol Education Program. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
6. Nikkila EA, Tikkanen MJ, Kuusi T. Gonadal hormones, lipoprotein metabolism and coronary heart disease. In: Oliver MF, Vedin A, Wilhelmsson C, eds. Myocardial infarction in women. New York: Churchill Livingstone Inc, 1986;34-43.
7. Dayton S, Hashimoto S. Recent advances in molecular pathology: a review. Cholesterol flux and metabolism in arterial tissue in atheroma. Exp Mol Pathol 1970;13:253-268.
8. Newman HA, Zilversmit DB. Quantitative aspects of cholesterol flux in rabbit atheromatous lesions. J Biol Chem 1962;237:2078-2084.
9. Nordestgaard BG, Wooten R, Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intimal-inner media. Arterioscler Thromb Vasc Biol 1995;15:534-542.
10. Nordestgaard BG, Nielsen LB. Atherosclerosis and arterial influx of lipoproteins. Curr Opin Lipidol 1994;5:252-257.
11. Wagner JD, Schwenke DC. Lipoprotein metabolism in the vessel wall. In: Rubanyi G, Kauffman R, eds. Estrogens and the vessel wall. Berkshire, UK: Harwood Academic Publishers, 1998;142-149.
12. Williams JK, Tabas L. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-561.
13. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-727.
14. Steinberg D. Antioxidants and atherosclerosis: a current assessment. Circulation 1991;84:1420-1425.
15. Steinbrecher UP, Wiztum JL, Parthasarathy S. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Arteriosclerosis 1987;7:135-143.
16. Berliner JA, Territo MC, Seranian A. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-1266.
17. Cushing SD, Berliner JA, Valente AJ. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990;87:5134-5138.
18. Palinski W, Rosenfeld ME, Yla-Herttuala S. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989;86:1372-1376.
19. Yla-Herttuala S, Palinski W, Butler SW, et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994;14:32-40,
20. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A 1987;84:7725-7729.
21. Kita T, Nagano Y, Yokode M, et al. Probucol prevents the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A 1987;84:5928-5931.
22. Sparrow CP, Doebber TW, Olszewski J. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J Clin Invest 1992;89:1885-1891.
23. Wagner JD, Zhang L, Williams JK. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in Cynomolgus monkeys. Arterioscler Thromb Vasc Biol 1996;16:1473-1480.
24. Gotto AM Jr, Pownall HJ, Havel RJ. Introduction to the plasma lipoproteins. Methods Enzymol 1986;128:3-41.
25. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol 1993;4:187-196.
26. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 1995;6:291-305.
27. Hui D, Brecht WJ, Hall EA. Isolation and characterization of the apolipoprotein E receptor from canine and human liver. J Biol Chem 1986;261:4256-4267.
28. Brindley DN. Metabolism of triacylglycerols. In: Vance DE, Vance J, eds. Biochemistry of lipids, lipoproteins and membranes. Amsterdam: Elsevier, 1992;171-203.
29. Bauer JE. Comparative lipid and lipoprotein metabolism. Vet Clin Pathol 1996;25:49-55.
30. Bauer JE. Diet-induced alteration of lipoprotein metabolism. J Am Vet Med Assoc 1992;201:1691-1694,
31. Brown MS, Goldstein JL. How LDL receptors influence cholesterol and atherosclerosis. Sci Am 1984;251:58-66.
32. Frohlich JJ, Pritchard PH. The clinical significance of serum high density lipoproteins. Clin Biochem 1989;22:417-423.
33. Watson TDG, Butterwick RF, McConnell M, et al. Development of methods for analyzing plasma lipoprotein concentrations and associated enzyme activities and their use to measure the effects of pregnancy and lactation in cats. Am J Vet Res 1995;56:289-296.
34. Tsutsumi K, Hagi A, Inoue Y. The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals. Biol Pharm Bull 2001;24:579-581.
35. Applebaum-Bowden D. Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol 1995;6:130-135.
36. Williams PT, Albers JJ, Krauss RM, et al. Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men. Atherosclerosis 1990;82:53-58.
37. Overturf ML, Loose-Mitchell DS. In vivo model systems: the choice of the experimental model for analysis of lipoproteins and atherosclerosis. Curr Opin Lipidol 1992;3:179.
38. Ginsberg HN. Lipoprotein physiology and its relationship to atherogenesis. Endocrinol Metab Clin North Am 1990;19:211-228.
39. Tall AR. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J Clin Invest 1990;86:379-384.
40. Chait A, Eisenberg S, Steinmetz A. Low density lipoproteins modified by lipid transfer protein have altered biological activity. Biochim Biophys Acta 1984;795:314-325.
41. Davidson MH. Implications for the present and directions for the future. Am J Cardiol 1973;71:32B-36B.
42. Bagdade JD, Ritter MC, Subbaiah PV, et al. Accelerated cholesteryl ester transfer in patients with insulin dependent diabetes mellitus. Eur J Clin Invest 1991;21:161-167.
43. Bagdade JD, Lane JT, Subbaiah PV, et al. Accelerated cholesteryl ester transfer in noninsulin dependent diabetes mellitus. Atherosclerosis 1993;104:69-77.
44. Bagdade JD, Wagner JD, Rudel LL, et al. Accelerated cholesteryl ester transfer and altered lipoprotein composition in diabetic Cynomolgus monkeys. J Lipid Res 1995;36:759-766.
45. Ha YC, Barter PJ. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol 1982;71B:265-269.
46. Koo C, Innerarity TL, Mahley RW. Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J Biol Chem 1985;260:11934-11943.
47. Barrie J, Nash AS, Watson TDG. Quantitative analysis of canine plasma lipoproteins. J Small Anim Pract 1993;34:226-231.
48. Wagner JD, Greaves KA, Schwenke DC, et al. Lipid and lipoproteins. In: Loeb WF, Quimby FW, eds. The clinical chemistry of laboratory animals. 2nd ed. Philadelphia: Taylor & Francis, 1999;181-228.
49. Bauer JE. Hyperlipidemias. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 5th ed. Philadelphia: WB Saunders Co, 2000;283-292.